To evaluate the generalizability of risk stratification thresholds we used stored samples from a substudy of the trial to compare the performance of different high-sensitivity cardiac troponin I assays (Abbott ARCHITECTSTAT and Siemens Atellica, Siemens Healthineers) and high-sensitivity cardiac troponin T (Roche Elycsys, Roche Diagnostics). Participants provided informed consent for additional blood sampling and storage, as described previously.20 (link)–22 (link) The analysis population was defined in the substudy using the same inclusion and exclusion criteria as for the trial population.
Free full text: Click here